Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11332502 Modified AAV capsid proteins and uses thereof

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
September 1, 2020
Date of Patent
May 17, 2022
Patent Application Number
17009536
Patent Citations
‌
US Patent 11091777 Synthetic combinatorial AAV capsid library for targeted gene therapy
‌
US Patent 10815279 Capsid-modified rAAV vector compositions and methods therefor
‌
US Patent 11000597 Engineered receptor/ligand system for delivery of therapeutic agents
‌
US Patent 10011640 Capsid-modified rAAV vector compositions and methods therefor
‌
US Patent 10308957 rAAV vectors and methods for transduction of photoreceptors and RPE cells
‌
US Patent 10426844 Capsid-mutated rAAV vectors and methods of use
‌
US Patent 10648000 rAAV vector compositions, methods for targeting vascular endothelial cells and use in treatment of type I diabetes
‌
US Patent 10723768 Capsid modified rAAV vectors and methods of use
‌
US Patent 10793606 Modified AAV capsid proteins and uses thereof
Patent Citations Received
‌
US Patent 12065467 High-transduction-efficiency rAAV vectors, compositions, and methods of use
0
‌
US Patent 11767346 Modified AAV capsid proteins and uses thereof
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11332502
Patent Primary Examiner
‌
Rachel B Gill
CPC Code
‌
C12N 7/00
‌
C12N 2750/14121
‌
C12N 2750/14145
‌
C12N 2320/32
‌
C12N 2750/14011
‌
C12N 15/1037
‌
C12N 2750/14143
‌
C12N 15/10
‌
A61P 27/02
‌
C07K 14/005
•••

Find more entities like US Patent 11332502 Modified AAV capsid proteins and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo